MEI Pharma, Inc. Skyrocketed
Tue, Nov 30, 2021 at 05:30 PM
MEI Pharma, Inc. (MEIP:NASDAQ) rocketted at $3.37, representing a gain of 37.6%. On Mon, Nov 29, 2021, MEIP:NASDAQ touched a New 2-Week Low of $2.45. The stock got featured on our News Catalysts scanner on Tue, Nov 30, 2021 at 07:57 AM in the 'BIOTECH' category. From Mon, Nov 15, 2021, the stock recorded 22.22% Up Days and 20.00% Green Days
About MEI Pharma, Inc. (MEIP:NASDAQ)
MEI Pharma Inc is an oncology company focused on the clinical development of novel therapeutics for cancer. The Company's portfolio of drug candidates includes Pracinostat, an oral histone deacetylase inhibitor.
Top 10 Gainers:
- Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 128.64%
- iFresh Inc. (IFMK:NASDAQ), 50%
- VOSO (VOSO:NASDAQ), 43.95%
- MEI Pharma, Inc. (MEIP:NASDAQ), 37.55%
- Pioneer Power Solutions, Inc. (PPSI:NASDAQ), 32.5%
- Ardelyx, Inc. (ARDX:NASDAQ), 32.24%
- ImmunoGen, Inc. (IMGN:NASDAQ), 29.89%
- Gritstone Oncology, Inc. (GRTS:NASDAQ), 25.71%
- CLNN (CLNN:NASDAQ), 22.37%
- GBS (GBS:NASDAQ), 22.22%